Patient Prism, a leader in conversational intelligence solutions, is excited to announce a strategic partnership with Sunbit, the company building financial technology for everyday expenses. This collaboration is set to revolutionize the healthcare industry by integrating access to cutting-edge financing options into Patient Prism’s AI-driven platform.

Amol Nirgudkar, CEO and Co-Founder of Patient Prism, stated, “Our partnership with Sunbit is a leap forward in aligning with our vision at Patient Prism, where marketing, sales, and operations converge seamlessly in healthcare. With Sunbit’s innovative patient financing solutions now part of our ecosystem, we’re enabling practices to reach new heights in growth and patient satisfaction and fundamentally transforming the patient experience.

Pre-qualification for financing reassures patients, enabling them to split their payment for treatment over time if they choose. Patients can now schedule their appointments with confidence that they will have fair, transparent, and no-fee pay-over-time options. They can now focus on receiving the treatment they need and deserve, with greater flexibility on how and when they pay, thus elevating both case acceptance and patient trust in the practice.”

This partnership signifies a commitment to providing healthcare practices with more than advanced technology; it’s about offering comprehensive solutions that address every aspect of practice management, including patient financing.

George Böhnisch, CTO of Patient Prism, added, “We are thrilled to announce our partnership with Sunbit, a leader in patient financing technology. This collaboration marks a significant milestone in our journey to enhance patient experiences and streamline dental practice operations. With our new integration, which leverages Patient Prism’s artificial intelligence and advanced neural networks, we can now offer a seamless and automated way for practices to offer financing options. This not only simplifies the process for patients but also empowers dental practices with a tool to increase accessibility to dental care. We believe this partnership will set a new standard in patient-practice interactions, merging technological innovation with compassionate care.”

Oded Vakrat, Sunbit’s VP of Platform Partnerships, said, “Patient Prism’s sophisticated AI delivers personalized, specific actions and insights that improve patient experience. The integration with Sunbit allows practices to provide care to more patients by leveraging the power of pre-visit patient pre-qualification. The integrated experience will help patients successfully manage the financial cost associated with unexpected treatment.”

More than 10,000 dental practices of all sizes rely on Sunbit’s industry-leading financial technology, which offers virtually every patient access to fair financing options within 30 seconds. The transparent and flexible payment options ease the administrative burden for practices while providing transparency to the consumer and eliminating unexpected fees and lengthy applications. Sunbit powers and manages the application and collection processes.

To learn more about how Patient Prism’s AI-driven platform is revolutionizing dental practices and enhancing patient communication, visit www.patientprism.com. Discover how the company's partnership with Sunbit empowers dental offices to provide patients with more accessible care options and improve overall case acceptance.

Despite challenging macroeconomic conditions, Neocis secured $20M in financing in 2023 to accelerate growth, with funding participation from Mirae Asset Financial Group and NVIDIA.

Neocis®, the global leader in robot-assisted dental implant surgery, announced today that the company has raised $20M in additional funding. This latest round of financing included Mirae Asset Capital/Mirae Asset Venture Investment, venture capital firms affiliated with the Mirae Asset Financial Group that invest in growth-stage healthcare and technology businesses, and NVentures, NVIDIA’s venture capital arm.

Headquartered in Miami, Neocis manufactures and markets Yomi®, dentistry’s first and only robotic surgical system cleared by the U.S. Food and Drug Administration (FDA). The Yomi platform, which has received a total of 16 FDA 510(k) clearances, assists clinicians during all phases of implant placement via streamlined digital planning and haptic guidance of surgical instrumentation, so users can deliver precise and efficient treatment. To date, more than 40,000 implants have been placed with robotic assistance. A dental implant is placed with Yomi approximately every six minutes, according to current data from Neocis.

"The latest investment is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” said Alon Mozes, Neocis’ co-founder and CEO. “We’re tremendously grateful to have the backing of our newest investors, including NVentures and Mirae Asset Financial Group, as well as our existing partners. This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry.”

Neocis, which was named one of South Florida's 50 fastest growing companies last year by the South Florida Business Journal, will use these additional funds to bolster a wide range of business initiatives from product development and sales enablement to clinical education. To keep pace with the company’s steady growth, Neocis moved into a larger space last summer. The new headquarters, which houses a state-of-the-art manufacturing facility, is located in Miami’s bustling Wynwood neighborhood.

"Neocis is bringing needed innovation to dentistry, and we couldn’t be more excited to support them in that mission,” said Mirae Asset Capital’s Investment Manager, Soojung Kim. “We look forward to working alongside the Neocis team to help them excel in a rapidly growing market and get Yomi in the hands of more providers.”

“Robotics and AI are changing the face of dentistry, enabling innovations that increase doctor efficiency and help them improve the quality of life for their patients,” said Mohamed “Sid” Siddeek, corporate vice president and head of NVentures. “Neocis is transforming dental implant procedures, demonstrating the benefits of robotics and AI in healthcare.”

To learn more about Neocis and the Yomi platform, visit neocis.com.

Introducing DSX, a new sales organization delivering the right products and the right service making it easier for dentists to equip their practices for clinical success and growth.

DSX (Dental Solutions and Technology), is the new sales organization from DENTALEZ representing products and services from multiple leading dental brands. We’ve gathered some of the most knowledgeable sales representatives you know and trust, combined them with a seasoned leadership team, and built a bundle of products that can better support clinicians with core equipment and high value merchandise.

Combining DENTALEZ brands: Star handpieces, Ramvac utility, Forest and Heritage operatory equipment, the new Imagine+ cabinet line, Columbia teaching aids, and Nevin Lab workstations with Porter Nitrous Oxide Systems and ILS Radiance cabinets, the DSX sales team has one of most comprehensive portfolios of products and smart solutions in the dental industry. Everything you need for existing practices to new office builds, is now at one point of contact.

DSX Sales Team—Viewed as the Experts

Who wants to be sold by someone that is simply regurgitating marketing jargon? Too often, lack of depth of knowledge related to the product and the dental profession renders the wrong purchase decision or no decision. This produces neither the breakthrough operational processes nor the blockbuster business model practices need to stay relevant to patient’s demands.

Clinicians want to know how their investment in technology and equipment will solve their pain points and how it complements their current process. “Product knowledge is a key component of consultative selling and will distinguish the new DSX (Dental Solutions and Technology), sales organization from the rest.” commented Carlos Martinez, Senior Director of Sales for DENTALEZ

Today’s fast paced innovative marketplace requires sales professionals to not only know their product but know the dental practice ecosystem surrounding the product. The DSX sales organization’s knowledge about both the product and the dental industry gives you the clinician the ability to engage in deeper, more consultative conversations. These conversations are bound to be much more productive and collaborative than the typical transactional sale. This power of knowledge makes the sales cycle as seamless as possible allowing you to get back to your field of expertise… dentistry and enhancing patients’ quality of life.

Technology and people are a winning combination in which the best mix of branded product performance and human talent will make the real difference. Welcome the new DSX (Dental Solutions and Technology), organization. Find your rep at DSXsales.com.  

As an expression of gratitude, Ivoclar ended its landmark anniversary year with a display of light on the new office building at the company headquarters in Liechtenstein: The building, which was inaugurated in the centenary year, was lit up in the company colours for several days in December, symbolically lighting the way to a bright future for the company.

At the end of the year, Ivoclar proudly looked back on twelve months of many different 100-year anniversary activities and events around the world, celebrating the company’s historic milestone. Exhibitions, special events for customers and international symposia as well as a series of festivities for company employees took place under the theme of “A Century of Innovation. “We used the centenary celebrations to say thank you to our customers, business partners and employees. They have all contributed to making Ivoclar a leading international dental company. We wish to thank everyone who helped us get to where we are today,” said Markus Heinz, who has been heading up the Group as CEO since last March.

Ivoclar – a pioneer of the dental industry

Ivoclar provided a visual grand finale to this very special year by illuminating the company’s head office building in Schaan, Liechtenstein, in the company colours of blue and green. “Just as smoothly as the colours blend into each other, we will transition from the past century of innovation into the next,” said Heinz. “We have played a significant part in shaping the dental industry and strive to continue being a leader in this field in the future.” To stay ahead of the game, Ivoclar relies on its inhouse research and development department, which is one of the biggest in the industry and the holder of numerous patents: for the blue lithium disilicate blocks (IPS e.max CAD) for example, which Ivoclar introduced to the general public at IDS 2005. At that time, competitors did not take this exceptionally strong and highly esthetic material very seriously. Nevertheless, the product known as IPS e.max CAD quickly gained immense popularity among customers and subsequently revolutionized the dental industry. The company is extremely proud of the fact that IPS e.max remains the top-selling all-ceramic system among dental laboratories and practices to this day.

An appreciation of employees

One of the highlights of the 100-year celebrations took place in Schaan, Liechtenstein, where the company, which was founded in 1923 in Zurich, Switzerland, has had its headquarters since 1933. It was the official 100-year commemoration ceremony and the grand opening of the new head office building in June. A few days later the company showed its appreciation for its employees by hosting a special family day party. Furthermore, the employees of the company’s 56 subsidiaries and branch offices celebrated the centenary at similar events throughout the world. “Our 3700 employees across the globe share the same values. They all give their best every day to help our customers put a smile on people’s faces. This common goal and strong connection were particularly palpable during this memorable year, across all national boundaries, and will continue to be with us in the future. Our teams are motivated and committed to achieving great things in the future. For this we would like to thank them,” said CEO Markus Heinz.

More information about the Ivoclar Group is available at ivoclar.com. 

Sonendo, Inc. (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced a partnership agreement with Dental Purchasing Group (DPG), a member-driven group purchasing organization (GPO) that provides independent and group dental practices with cost savings programs. As a result of the agreement, DPG members can adopt and implement the GentleWave Procedure into their practices to provide their patients with elevated root canal therapy. A simpler and less invasive alternative to traditional treatment, the GentleWave Procedure has been performed more than one million times and counting.

DPG recognizes that dental practice owners are increasingly faced with declining revenue and limited solutions, and is committed to helping them increase profitability. The ideal partner, Sonendo provides clinicians with the technology they need to overcome challenging cases and perform high-quality root canal treatment.

"We are excited to partner with Sonendo, a dental technology leader and developer of the GentleWave System," said Seth Josephs, founder of DPG. "At DPG, we are committed to bringing innovative solutions to our members that will enhance practice growth and profitability. Together we can achieve more!"

With the GentleWave Procedure, most patients report mild to no pain and are treated in a single visit, leading to increased efficiencies and better patient experiences.

“With members in more than 40 states, DPG is one of the largest dental-specific GPOs in the U.S. and we are pleased to partner with them in this capacity,” said Bjarne Bergheim, President and CEO of Sonendo. “We are confident that the GentleWave Procedure will bring DPG members a slew of benefits, from simplified workflows to better patient outcomes – all of which will positively impact profitability and the overall patient experience.”

This news comes off the heels of Sonendo announcing a strategic partnership with another GPO earlier this month. Last year, the Company announced agreements with two endodontic dental service organizations (DSOs).

For more information about Sonendo and the GentleWave System, please visit www.sonendo.com. To find a GentleWave doctor in your area, please visit www.gentlewave.com.

About Sonendo

Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave® System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave® System can improve the workflow and economics of dental practices.

Sonendo is also the parent company of TDO® Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO® Software integrates practice management, imaging, referral reporting and cone beam computed tomography imaging, and offers built-in communication with the GentleWave® System.

For more information on Sonendo, visit www.sonendo.com. For more information on the GentleWave® System, visit www.gentlewave.com/doctor.

Henry Schein Orthodontics (HSO), the orthodontics business of Henry Schein, Inc. (Nasdaq: HSIC), expanded its product portfolio with the launch of the Carriere® Motion Pro™ bite corrector¹. The newest addition to the Motion portfolio is fitted to teeth to treat the anteroposterior dimension of a patient’s occlusion, allowing clinicians to achieve a Class I platform within an average of three to six months² of treatment, and before placing brackets or aligners. Watch this video to learn more about the benefits and features of the Carriere Motion Pro.

With the unique ability to treat both Class II and Class III patients with one device, Carriere Motion Pro bite corrector features a custom-designed drop-in hook to enhance treatment versatility. The wider reinforced cuspid pad hook ensures a consistent distribution of elastic forces, while the hook’s deep undercut simplifies elastic engagements and effectively secures the Force Oral Elastics, a portfolio of products designed to work seamlessly with Motion appliances to provide optimal results. The latest addition to the portfolio, the Force 3 Elastics, will be available soon.

The new Carriere Motion Pro™ bite corrector also features a built-in scribe line, flat faces, straight edges, and a recessed dimple, helping to provide intuitive and accurate placement. This efficient design provides fast and predictable treatment, and the condyle shaped joint is designed to facilitate more natural and controlled movement.

“As Henry Schein Orthodontics continues to invest in innovative orthodontic products, we are pleased to announce the latest addition of the new Carriere Motion Pro,” said Christophe Carsault, Vice President and General Manager, Henry Schein Orthodontics. “Just as the original Motion appliance revolutionized the way many orthodontists approach sagittal correction, we are confident that the new Carriere Motion Pro™ will similarly advance orthodontics and help enhance our customers capabilities to achieve more efficient and predictable aligner and orthodontic treatment. We look forward to additional educational offerings and supporting our customers’ innovation to help them deliver a new standard of care with the Carriere Motion Pro.”

Like the Carriere Motion Pro, the original Motion appliances were created by Dr. Luis Carrière, who also popularized the SAGITTAL FIRST™ philosophy, an approach to care that helps standardize, simplify, and shorten Class II and Class III treatment time by treating the AP dimension at the beginning of treatment².

“I’m happy to introduce the Carriere Motion Pro as a solution of honest and sophisticated design driven to maximize treatment efficiency and precision as well as patient comfort with an absolute ease of use,” said Dr. Luis Carrière.

To learn more about the Carriere Motion Pro bite corrector, please visit Motion Pro | Henry Schein® Orthodontics™ (henryscheinortho.com), email USASales@HenryScheinOrtho.com, or call (760) 448-8600.

1. Motion Pro bite corrector patent pending. Not available in all countries. See your local distributor for more information.

2. Data on file

3. Coming soon

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 24,000 Team Schein Members worldwide, Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.6 billion in 2022, and have grown at a compound annual rate of approximately 12.1 percent since Henry Schein became a public company in 1995.

Delta G Ventures, founded in 2015 as a strategic advisory firm in the life sciences industry, announced today that it has greatly expanded its advisory services team. Joining managing partner Lars Janson are two additional managing partners: Bart Doedens and Russ Bonafede.

Doedens and Bonafede have served as CEOs for several health-care companies, leading them while introducing innovative technologies to the global market. This new managing partner team represents decades of comprehensive experience, knowledge, and leadership in developing and commercializing life science technologies and will allow DGV to service a greater number of clients seeking executive guidance.

In addition to the strengthened leadership team, more than 10 associates have joined the firm representing subject matter expertise in multiple areas. Please see https://deltagventures.com/member-type/our-team/ for a listing and profiles of this growing group of advisors.

Lars Janson, Founder and Managing Partner said: "The addition of Bart and Russ to the leadership team provides a unique blend of expertise and longevity rarely found with other firms focused on the life science sector. We are excited to combine our expertise to help our clients succeed in their endeavors.”

As we move into 2024, DGV plans to grow its robust client list and offer a broader range of services. Services include enterprise strategy development, business unit start-up, and new market introduction. A comprehensive list of services can be found at https://deltagventures.com/services/. For more information, contact DGV at https://deltagventures.com/contact-us/.

About Delta G Ventures

DGV was established in 2015 as a strategic advisory services firm focused on the life science industry. The company, consisting of managing partners each with more than 30 years of experience and expert associates worldwide, offers comprehensive experience, knowledge, and leadership in the development and commercialization of life science technologies in the dental, cardiovascular, neurovascular, endovascular, orthopedic, ophthalmology, transport chairs, and wound-management sectors. The company focuses on being an extension of its clients’ businesses with a “their success is our success” mentality that drives its day-to-day operations. DGV is located in Palm Beach County, Florida, and services national and international customers.

Affordable Care, LLC, America's largest dental support organization (DSO) focused on tooth replacement services, announced today that Chief Executive Officer Gene Kirtser will retire from the company at the end of February 2024. Kirtser informed the Board last year of his intention to retire, and a search for a new CEO was started to support a seamless transition.

Pete Bridgman will succeed Kirtser as the new Chief Executive Officer.

"The Affordable Care Board of Directors expresses its deep gratitude to Gene for his strong leadership over the last six plus years," said Joe Delaney, Chairman of the Board for Affordable Care. "Gene recruited an outstanding leadership team to Affordable Care, expanded the company's services and built tight alignment between doctors and the DSO. The company saw tremendous growth under his leadership and has a very bright future."

During Kirtser's tenure, Affordable Care supported the expansion of patient access to high-quality and affordable tooth replacement care, growing from 220 to 440 affiliated dental practices across 43 states.

"It's been a privilege to lead Affordable Care through a time of significant transformation and growth," said Kirtser. "I am proud of our team and the many accomplishments achieved together, along with the esteemed doctors from across the Affordable Care supported practice network whose expertise, compassion and commitment have been the cornerstone of Affordable Care's mission to changing patient lives for the better."

He added, "I look forward to seeing the continued success of this incredible organization."

Appointment of Pete Bridgman as Affordable Care CEO

Pete Bridgman is a veteran consumer healthcare and retail executive, having served most recently as Chief Executive Officer of Visionworks, the sixth largest optical retailer in the U.S., and as Chief Network Officer of VSP Vision, the second largest U.S. vision care company, following VSP's acquisition of Visionworks in 2019. Prior to joining Visionworks, Pete previously served as President of Pearle Vision and President of LensCrafters – both brands under EssilorLuxottica, the world's largest vision care company.

"Pete is a mission-driven, highly-qualified leader who brings an excellent mix of healthcare and retail experience to Affordable Care," explained Delaney. "The Board of Directors is thrilled to have Pete lead Affordable Care through this next stage of growth, and we are highly confident that he can help this successful organization continue to have a profound impact on the lives of patients."

Bridgman shared, "I am honored and excited to lead the next phase of Affordable Care as CEO and look forward to building on the strong foundation that Gene and this team have created. I have tremendous respect for the impact that Affordable Care and its supported practices have made on the lives of patients for nearly 50 years. I'm eager to begin working with the team in extending the company's leading position in providing life-changing tooth replacement services." 

With 500-watt lasers and a square build plate, the TruPrint 2000 is further optimized for mass production // More productivity and quality for users in the dental and medical technology industries // Up to 36 percent more partial dentures in one build

The high-tech company TRUMPF has further increased the productivity of its TruPrint 2000 3D printer. The TruPrint 2000 now comes with a square build plate and the increased power of a 500-watt integrated fiber laser offered as an alternative to the 300-watt laser in the basic configuration. Using a square build plate, dental technology companies, for example, can print up to 36 percent more removable partial dentures than they could on a comparable round build plate. TRUMPF is introducing the new 3D printer to the U.S. market at Lab Day Chicago, the largest gathering of the dental laboratory community in North America, which takes place February 22 to 24, 2024.

"The updated TruPrint 2000 is further optimized for mass production. Users from all industries benefit from the machine's high productivity," says Miguel Verdejo, additive manufacturing product & project manager at TRUMPF Inc’s Laser Technology Center in Michigan.

As a multi-laser version, the TruPrint 2000 has two lasers. Both lasers can process the entire build plate simultaneously, resulting in optimized throughput for production.

"The TruPrint 2000 is productive, precise, and produces high quality parts," says Verdejo. According to the highest medical standards, medical technology manufacturers use the 3D printer to produce skull plates, spine cages or knee joints made of titanium, for example. "In addition to the upgrades of the TruPrint 2000, the machine has the process monitoring and calibration features found in all TruPrint machines. Ensuring repeatable and high-quality parts is the top priority for TRUMPF 3D printing, especially in critical areas such as medical and dental technology."

TruPrint 2000 especially flexible due to variable spot size

With its motorized beam expander, the TruPrint 2000 automatically adjusts the spot diameter of the laser to the task at hand. Depending on the application, the spot diameter is 55 or 80 micrometers. The 80-micrometer spot enables higher productivity. Users can use the 55-micron spot when special metal powders require a higher energy density. The introduction of the 80-micron spot size brings the TruPrint 2000 in line with the rest of the machines in the TruPrint portfolio.

"With this standardization, users can now easily transfer the parameters for printing their parts from one machine type to another, such as from a TruPrint 2000 to a TruPrint 1000 or TruPrint 3000, which enables for more flexible production," says Verdejo. 

Company expands AI-detection capabilities with more than 30 new AI algorithms, helping tens of thousands of clinicians provide expanded patient-centric clinical care to millions of people

VideaHealth, the leading dental artificial intelligence (AI) platform, today announced the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance for Videa Dental Assist, which includes more than 30 AI algorithms and expands AI detections to cover all of the most common dental diseases.

Florian Hillen, CEO of VideaHealth, said, “This is one of the largest, most impactful FDA clearances in the history of healthcare and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients.”

The clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages three years and older as well as many other AI models that allow for subtle detections across all ages, better workflow and time-savings. Many of these detections are the first of their kind to be issued by a regulatory agency anywhere in the world, including the first pediatric radiology AI clearance in dentistry.

Dr. Tim Quirt, Senior Vice President of Clinical Operations at Heartland Dental shared, “It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand. We are proud to partner with VideaHealth in this fast-moving field because their vision, mission and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint.”

Thousands of clinicians have already selected VideaAI as their dental AI tool of choice, using it daily to provide the best possible care for millions of patients. With today’s announcement, VideaHealth is now the first dental AI company to offer insights for virtually every disease state.